Sign up to save your podcasts
Or
Share First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
3030 ratings
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
More shows like Lung Cancer Update
View all
NEJM This Week
320 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Breast Cancer Update
69 Listeners
Hematologic Oncology Update
76 Listeners
Prostate Cancer Update
13 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
13 Listeners
Dermatologic Oncology Update
0 Listeners
Lung Cancer CancerCare Connect Education Workshops
6 Listeners
Research To Practice | Oncology Videos
116 Listeners
ASCO Daily News
57 Listeners
The Long Run with Luke Timmerman
124 Listeners
ASCO Guidelines
44 Listeners
Lung Cancer Considered
29 Listeners
Oncology Today with Dr Neil Love
56 Listeners
Business Of Biotech
86 Listeners
Two Onc Docs
185 Listeners